**Source:** Jumeili (聚美丽) · **Date:** 2026-10-17 · **Category:** Regulation / Enforcement *原文:立案调查!45批次化妆品“暴雷”* China's National Medical Products Administration published Notice No. 36 of 2026 on October 15 listing 45 batches of cosmetics that failed sampling inspection, and has opened investigations into the products and the companies named. The failures span eight product types: sunscreen, shampoo and hair care, skincare, sheet masks, bath products, whitening and cream products, toothpaste and cleansers. Jumeili frames the notice as a continuation of a tougher enforcement line. Five months earlier, in May 2026, Guangzhou Baiyun Qianfei Cosmetics was punished at the upper end of the scale for supplying false information and concealing the true situation — a case the regulator publicised as a warning. The recurrence across so many categories suggests inspectors are working through the full cosmetics register rather than focusing on one hot category. The practical read-across for brands and contract manufacturers is unglamorous but immediate: batch-level documentation, sunscreen SPF verification, and the gap between filed formulas and what actually ships. Jumeili's fuller analysis s
相关内容
监管视角:可溶性微晶贴的合规路径与标准走向
可溶性微针产品在监管上存在「化妆品与医疗器械」双路径:作用于皮肤表面、以护肤功效宣称的产品走化妆品备案;涉及创面、痤疮治疗等医疗场景的则需要医疗器械注册。2023 年国内首款聚合物微针二类医疗…
电商平台美妆抽检合格率提升,下一个增长曲线在哪里
电商平台美妆抽检合格率提升近期持续升温。数据显示,第四季度相关指标中,线上渠道占比达到55%,行业讨论度明显提高。本文结合公开信息与平台数据,拆解下一个增长曲线在哪里。…
儿童化妆品监管细则趋严,从供给端看竞争格局
儿童化妆品监管细则趋严近期持续升温。数据显示,第三季度相关指标中,新品发布数量同比增加2.7倍,行业讨论度明显提高。本文结合公开信息与平台数据,拆解从供给端看竞争格局。…
新原料备案数量再创新高,渠道变化带来的新红利
新原料备案数量再创新高近期持续升温。数据显示,第二季度相关指标中,头部品牌集中度升至15.8%,行业讨论度明显提高。本文结合公开信息与平台数据,拆解渠道变化带来的新红利。…